Literature DB >> 17964352

The operation of the century: total hip replacement.

Ian D Learmonth1, Claire Young, Cecil Rorabeck.   

Abstract

In the 1960s, total hip replacement revolutionised management of elderly patients crippled with arthritis, with very good long-term results. Today, young patients present for hip-replacement surgery hoping to restore their quality of life, which typically includes physically demanding activities. Advances in bioengineering technology have driven development of hip prostheses. Both cemented and uncemented hips can provide durable fixation. Better materials and design have allowed use of large-bore bearings, which provide an increased range of motion with enhanced stability and very low wear. Minimally invasive surgery limits soft-tissue damage and facilitates accelerated discharge and rehabilitation. Short-term objectives must not compromise long-term performance. Computer-assisted surgery will contribute to reproducible and accurate placement of implants. Universal economic constraints in healthcare services dictate that further developments in total hip replacement will be governed by their cost-effectiveness.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17964352     DOI: 10.1016/S0140-6736(07)60457-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  504 in total

1.  Monitoring the one year postoperative infection rate after primary total hip replacement.

Authors:  David J Biau; Philippe Leclerc; Simon Marmor; Valerie Zeller; Wilfrid Graff; Luc Lhotellier; Philippe Leonard; Patrick Mamoudy
Journal:  Int Orthop       Date:  2011-12-30       Impact factor: 3.075

2.  In brief: Crowe's classification: arthroplasty in developmental dysplasia of the hip.

Authors:  Muhammad Umar Jawad; Sean P Scully
Journal:  Clin Orthop Relat Res       Date:  2011-01       Impact factor: 4.176

3.  Accuracy of acetabular cup placement in computer-assisted, minimally-invasive THR in a lateral decubitus position.

Authors:  Ernst Sendtner; Tibor Schuster; Michael Wörner; Thomas Kalteis; Joachim Grifka; Tobias Renkawitz
Journal:  Int Orthop       Date:  2010-05-21       Impact factor: 3.075

4.  Not the last word: arthrostasis.

Authors:  Joseph Bernstein
Journal:  Clin Orthop Relat Res       Date:  2015-10-06       Impact factor: 4.176

5.  Working toward benchmarks in orthopedic OR efficiency for joint replacement surgery in an academic centre.

Authors:  Paule E Beaulé; Aaron A Frombach; Jae-Jin Ryu
Journal:  Can J Surg       Date:  2015-12       Impact factor: 2.089

6.  Alteration of the RANKL/RANK/OPG System in Periprosthetic Osteolysis with Septic Loosening.

Authors:  Long Wang; Zixun Dai; Jie Xie; Hao Liao; Cheng Lv; Yihe Hu
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

7.  Is Parkinson's Disease Associated with Increased Mortality, Poorer Outcomes Scores, and Revision Risk After THA? Findings from the Swedish Hip Arthroplasty Register.

Authors:  Alex Leigh Wojtowicz; Maziar Mohaddes; Daniel Odin; Erik Bülow; Szilard Nemes; Peter Cnudde
Journal:  Clin Orthop Relat Res       Date:  2019-06       Impact factor: 4.176

8.  MyHip: supporting planning and surgical guidance for a better total hip arthroplasty : A pilot study.

Authors:  Jérôme Schmid; Christophe Chênes; Sylvain Chagué; Pierre Hoffmeyer; Panayiotis Christofilopoulos; Massimiliano Bernardoni; Caecilia Charbonnier
Journal:  Int J Comput Assist Radiol Surg       Date:  2015-04-01       Impact factor: 2.924

9.  Patient-level clinically meaningful improvements in activities of daily living and pain after total hip arthroplasty: data from a large US institutional registry.

Authors:  Jasvinder A Singh; David G Lewallen
Journal:  Rheumatology (Oxford)       Date:  2013-02-04       Impact factor: 7.580

10.  Common Medical Comorbidities Correlated With Poor Outcomes in Hip Periprosthetic Infection.

Authors:  Daniel J Cunningham; Joseph J Kavolus; Michael P Bolognesi; Samuel S Wellman; Thorsten M Seyler
Journal:  J Arthroplasty       Date:  2017-03-31       Impact factor: 4.757

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.